CAS: 17289-26-8 - 1-Methyl-4-Formyl-imidazole
Formula:C5H6N2O
InChI:InChI=1/C5H6N2O/c1-7-2-5(3-8)6-4-7/h2-4H,1H3
- Synonyms:
- 1-Methyl-1H-Imidazole-4-Carboxaldehyde
- 1-Methyl-1H-imidazole-4-carboxaldehyde 97%
- N-Methyl-imidazole-4-carbaldehyde
- 1-Methyl-1H-imidazole-4-carbaldehyde
1-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE
CAS:17289-26-8
Formula:
C5H6N2O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
110.1139
Ref: IN-DA00AOLA
| 1g | 89.00 € | ||
| 5g | 176.00 € | ||
| 10g | 457.00 € | ||
| 100mg | 31.00 € | ||
| 250mg | 47.00 € | ||
| 500mg | 64.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
1-Methyl-1H-imidazole-4-carbaldehyde
CAS:17289-26-8
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
110.11599731445312
Ref: 10-F065298
| 1g | 56.00 € | ||
| 5g | 245.00 € | ||
| 10g | 370.00 € | ||
| 250mg | 27.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
1-Methyl-1H-imidazole-4-carboxaldehyde
CAS:17289-26-8
Formula:
C5H6N2O
Purity:
97%
Color and Shape:
khaki to brown fused solid
Molecular weight:
110.11g/mol
Ref: 54-OR4398
| 1g | 509.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
1-Methyl-1H-imidazole-4-carbaldehyde
CAS:17289-26-8
1-Methyl-1H-imidazole-4-carbaldehyde is an Imidazole derivative. Imidazoles are the most prominent heterocyclic scaffolds found in medical …
Formula:
C5H6N2O
Purity:
Min. 95%
Color and Shape:
Slightly Yellow Powder
Molecular weight:
110.11 g/mol
Ref: 3D-FM63129
| 1g | 310.00 € | ||
| 2g | 465.00 € | ||
| 5g | 770.00 € | ||
| 10g | 1,160.00 € | ||
| 500mg | 194.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
1-Methyl-1H-imidazole-4-carbaldehyde
Controlled ProductCAS:17289-26-8
Applications 1-Methyl-1H-imidazole-4-carbaldehyde (cas# 17289-26-8) was identified in the methanolic extract of red Vitis Vinifera peel. …
Formula:
C5H6N2O
Color and Shape:
Neat
Molecular weight:
110.11
Ref: TR-M222513
| 50mg | 92.00 € | ||
| 100mg | 128.00 € | ||
| 500mg | 422.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
